Published on
January 16, 2024
- 13:39 GMT
ConserV Bioscience ARBO-SAL project has been awarded UK Aid funding by the UK Vaccine Network, delivered by Innovate UK
LONDON, UNITED KINGDOM, January 16, 2024 /EINPresswire.com/ -- ConserV Bioscience Limited (“ConserV”), a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases, has been awarded …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
